- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06951607
Management of Proximal Interphalangeal (PIP) Joint Injuries
April 22, 2025 updated by: Unity Health Toronto
An Innovative Approach to the Management of Proximal Interphalangeal (PIP) Joint Injuries
This project seeks to compare the treatment efficacy of two different approaches to treating interphalangeal joint (PIP) joint injuries.
The investigators will compare two participant groups undergoing treatment using the current treatment standard (Coban wrap) as well as an innovative treatment approach (neoprene sleeve) in treating the PIP joint injury.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Hand injuries, specifically those involving the proximal interphalangeal joint (PIP) can be difficult to treat.
These stubborn injuries leave patients with pain, edema, and limitation in function and changes in the aesthetics of the hand.
This project would randomize patients with PIP joint injuries including dislocation, volar plate, intra-articular fracture and chip avulsion fracture with ligamentous injury into two groups.
The first group will receive the usual treatment including active range motion, edema control - contrast bath and coban.
The second group would receive similar treatment except a custom neoprene sleeve will be used in place coban.
Outcome measures would include: Numeric Pain Rating Scale (NPRS), measure of patient satisfaction and compliance with the coban vs a custom neoprene sleeve and a measure of hand function (Patient Rated Wrist/Hand Evaluation) as well as a range of motion and edema.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Daniela Bellicoso
- Phone Number: 4169021877
- Email: Daniela.Bellicoso@unityhealth.to
Study Contact Backup
- Name: Keum Yung Choi
- Email: KeumYung.Choi@unityhealth.to
Study Locations
-
-
-
Toronto, Canada, M5B 1W8
- Unity Health Toronto
-
Contact:
- Daniela Bellicoso
- Phone Number: 4169021877
- Email: Daniela.Bellicoso@unityhealth.to
-
Contact:
- Keum Yung Choi
- Email: KeumYung.Choi@unityhealth.to
-
Contact:
- Susan Ellis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion criteria
- Read/write and speak/understand English
- Capable of understanding the various questionnaires that will be employed to collect outcome measures
Exclusion Criteria:
- Participants who do not meet all of the aforementioned criteria
- Participants with any injuries specific to the treatment finger, or if there is any underlying disease affecting the PIP joint
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Coban wrap
The Coban wrap is a compressive adhesive bandage used to joint injuries.
Participants in this arm will receive a Coban wrap as a form of treatment with outcome measures occurring at the initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
A Coban bandage or wrap is a self-adhering elastic wrap that sticks to itself but not to skin or clothing.
It is commonly used as a wrap on limbs due to its ability to adhere to itself and not loosen.
Coban is often used as a compression bandage
|
|
Experimental: Neoprene Sleeve
Neoprene sleeve is an innovative treatment approach, it consists of a synthetic rubber-like material used to provide compressive support.
Participants in this arm will receive a sleeve as a form of treatment with outcome measures occurring at the initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
Neoprene sleeve is an innovative treatment approach, it consists of a synthetic rubber-like material used to provide compressive support.
Neoprene sleeves can provide protection, light compression and mild extension support while allowing full finger flexion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Edema
Time Frame: The outcome measures will be collected at various intervals, such as initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
The aim of the current study is to compare the treatment efficacy of a custom neoprene sleeve vs. a coban wrap in treating PIP joint injuries.
In order to measure to measure treatment changes in edema (swelling) for PIP joint injuries.
Edema will be measured using an instrument consisting of ring gage to determine whether the patient has experienced a decrease in swelling based on the circumferential numerical measurement comparison from their previous visit.
|
The outcome measures will be collected at various intervals, such as initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
|
Changes in Pain
Time Frame: The outcome measures will be collected at various intervals, such as initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
The aim of the current study is to compare the treatment efficacy of a custom neoprene sleeve vs. a coban wrap in treating PIP joint injuries.
The second primary outcome measure of interest is the level of pain that a patient may be experiencing at various intervals post injury, which can be measured using the Numeric Pain Rating Scale (NPRS).
|
The outcome measures will be collected at various intervals, such as initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of Motion
Time Frame: The outcome measures will be collected at various intervals, such as initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
To measure range of motion during patient visit intervals, clinicians will be using an instrument known as a goniometer to determine the extent of which the patient has regained their range of motion post injury between the two treatment conditions (Coban wrap vs. neoprene sleeve).
|
The outcome measures will be collected at various intervals, such as initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
|
Function and Appearance
Time Frame: The outcome measures will be collected at various intervals, such as initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
To measure function and appearance, clinicians will be administering the Patient Rated Wrist/Hand Evaluation (PRWHE) to determine the extent to which patients report regaining the function of their finger joints post injury, the scale includes a section which addresses patients' perceptions around appearance.
|
The outcome measures will be collected at various intervals, such as initial visit, 2 weeks, 4 weeks, 3 months and 6 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Susan Ellis, Unity Health Toronto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2025
Primary Completion (Estimated)
December 31, 2025
Study Completion (Estimated)
March 31, 2026
Study Registration Dates
First Submitted
March 18, 2025
First Submitted That Met QC Criteria
April 22, 2025
First Posted (Actual)
April 30, 2025
Study Record Updates
Last Update Posted (Actual)
April 30, 2025
Last Update Submitted That Met QC Criteria
April 22, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-240
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The research will be published and disseminated within the organization and/or in a scientific journal.
IPD Sharing Time Frame
After the data has been collected and analyzed.
IPD Sharing Access Criteria
Only the study personnel have access to the study information.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Interphalangeal Joint Injury
-
National Health Service, United KingdomUniversity of BradfordCompletedVolar Plate Injury of the Proximal Interphalangeal JointUnited Kingdom
-
Insel Gruppe AG, University Hospital BernRecruitingProximal Interphalangeal Joint StiffnessSwitzerland
-
NYU Langone HealthRecruitingProximal Interphalangeal Joint StiffnessUnited States
-
Onur GültekinCompletedFinger Fracture | Finger Sprain | Ligament Injury of the Finger | Proximal Interphalangeal (PIP) Joint InjuryTurkey
-
Schulthess KlinikCompletedDistal Interphalangeal Arthroplasty | Distal Interphalangeal ArthrodesisSwitzerland
-
Vicenç Punsola IzardCompletedProximal Interphalangeal Finger Joint ContracturesSpain
-
Waldfriede HospitalRecruitingProximal Interphalangeal Joint Fracture of the HandGermany
-
National Cheng-Kung University HospitalRecruitingFinger Proximal Interphalangeal Joint ContractureTaiwan
-
Central Hospital, Nancy, FranceUnknownInterphalangeal; Osteoarthritis, Proximal (Bouchard)France
-
Vicenç Punsola IzardCompletedJoint Deformities, Acquired | Flexion Contracture of Proximal Interphalangeal JointSpain
Clinical Trials on Coban wrap
-
DeRoyal Industries, Inc.Royal College of Surgeons, Ireland; Enterprise Ireland; Tyndall National InstituteCompletedVenous Leg Ulcer | Venous Insufficiency of LegIreland
-
University of Missouri-ColumbiaTerminatedBurns | Hand InjuriesUnited States
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR); University of Alberta; Vermont...TerminatedHypothermia in Premature InfantsCanada
-
BioLab HoldingsSerena GroupRecruitingUlcer | Diabetic Foot Ulcer | Venous Leg Ulcer | Leg Ulcers | Venous Ulcer | Ulcer Foot | Venous Leg Ulcer (VLU) | Foot Ulcer Chronic | DFUUnited States
-
Aksaray University Training and Research HospitalUnknown
-
BioLab HoldingsSerenaGroup, Inc.RecruitingDiabetic Foot | Ulcer | Leg Ulcer | Diabetic Foot Ulcer | Venous Leg Ulcer | Foot Ulcer, Diabetic | Ulcer Foot | Leg Ulcers Venous | DFUUnited States
-
Henry Ford Health SystemTerminatedHeart Failure; With DecompensationUnited States
-
Khon Kaen UniversityCompletedChild | Prevention | Perioperative HypotensionThailand
-
Grubnik VolodymyrCompletedGastro Oesophageal Reflux Disease
-
Capsicure, LLCBioLab HoldingsRecruitingWound; Foot | Venous Leg Ulcer | Diabetic Foot Ulcer (DFU)United States